(reported by the Company)
No items found
Vitrafy, Australia’s exciting new Bio Tech Company leading the way in innovative new patient orientated outcomes. Vitrafy is revolutionising the delivery of existing and emerging cell-based therapies from the research laboratory to the patient bedside. Giving your loved one the best chance of coming home. Cryopreservation plays a critical role in the biomedical life science industry. Current and emerging cellular therapies require successful cryopreservation of sensitive biological material that to-date, have had notoriously low and inconsistent success rates. Vitrafy have developed new, fully patented, cold chain solutions for the advancement in biomedical cryopreservation. These include a cryopreservation algorithm, freezing apparatus’, thawing apparatus’, tailored racking and packing solutions and a completely integrated software solution that includes data collection, reporting and processing automation.
|Category:||Hardware & devices, Health & biotech|
|ASX Listing Code (if applicable):|
|Year of Commencement:||2018|
Melbourne, Victoria 3000, AU